Emergent BioSolutions Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2011 Annual Meeting of Stockholders held on May 19, 2011. The filing was submitted on May 23, 2011, by Emergent BioSolutions Inc., a Delaware corporation.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Revenue, profit, cash flow, margins, debt, and liquidity figures are not provided in this document.
Material Changes and Voting Results
A total of 33,715,098 shares were present or represented by proxy, representing approximately 95.18% of the 35,424,190 outstanding shares entitled to vote. Four proposals were considered and approved:
- Proposal 1 (Director Election): Zsolt Harsanyi, Ph.D., Louis W. Sullivan, M.D., and Marvin L. White were elected as Class II directors for three-year terms. All nominees received significant majority support.
- Proposal 2 (Auditor Ratification): Stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2011.
- Proposal 3 (Executive Compensation): An advisory vote to approve the compensation of named executive officers was approved.
- Proposal 4 (Compensation Vote Frequency): Stockholders voted to hold future advisory votes on executive compensation every year.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the disclosure of stockholder voting outcomes.
Key Facts for Investor Verification
- Verify the specific terms of the newly elected directors' three-year terms.
- Confirm the engagement letter details with Ernst & Young LLP for the 2011 fiscal year.
- Review the definitive proxy statement dated April 7, 2011, for detailed executive compensation data referenced in Proposal 3.
- Note that the company has committed to annual advisory votes on executive compensation per Proposal 4.